Information about Pharmadefi
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0437.576.896

VAT liability
Yes
Established
29-05-1989
Last balance sheet year
2024
Company size
Medium-sized 3,3 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Pharmadefi

2024 2023 2022 2021
Profit/Loss 219,893 48 % 148,771 -37 % 235,695 171 % 87,117
Equity 513,701 75 % 293,808 103 % 145,037 1453 % 9,342
Gross margin 754,719 5 % 720,371 -5 % 757,437 28 % 592,983
Employees 3.3 4.2 4.7 4.6

Publications from Pharmadefi

Date Publication
14-09-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Resignations, Appointments (FR)
08-11-2019 Resignations, Appointments (FR)
10-01-2017 Registered Office (FR)
20-07-2012 Resignations, Appointments (FR)
24-07-2007 Renewal Mandate(s) (FR)

Frequently asked questions

What is the VAT number of Pharmadefi?
The VAT number of Pharmadefi is BE 0437.576.896.
Wat is the PEPPOL ID of Pharmadefi?
There is no information available about the PEPPOL ID of Pharmadefi or the company is not yet registered on the PEPPOL network.
When was Pharmadefi founded?
Pharmadefi was founded on 29-05-1989.
What is the address of Pharmadefi?
The current registered office of Pharmadefi is located at Route de Luxembourg 97, 6700 Arlon.
When was the last time Pharmadefi filed their annual financial statements?
The most recent financial statements of Pharmadefi were filed on 23-05-2025.
How many employees does Pharmadefi have?
There are 3,3 FTEs working at Pharmadefi according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharmadefi?
At the time of its most recent financial statements, Pharmadefi did not publish any turnover figures. Pharmadefi reported a gross margin of €754,719.31.